ClinicalTrials.Veeva

Menu
T

TTS Research | Boerne, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Dupilumab
Omalizumab
Amlitelimab
Lebrikizumab
Rocatinlimab
Ensifentrine
Ciclesonide Hydrofluoroalkane
SAR440340
SAR443765
MK-4482

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 26 total trials

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.

Enrolling
Asthma
Drug: Placebo
Drug: Rocatinlimab

This study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease (COP...

Enrolling
Chronic Obstructive Pulmonary Disease (COPD)
Drug: Astegolimab
Drug: Placebo

This is a parallel, Phase 2, global, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, four-arms study for treatment.The purpo...

Active, not recruiting
Asthma
Drug: Placebo
Drug: Amlitelimab

This is a Phase 2b, global, multicenter, randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the efficacy, saf...

Enrolling
Asthma
Drug: Placebo
Drug: Lunsekimig

This is a parallel, Phase 3, 2-arm study to evaluate the efficacy and long-term safety of dupilumab treatment in children 2 to \<6 years of age with...

Enrolling
Wheezing
Asthma
Drug: Placebo
Drug: Dupilumab
Locations recently updated

This is a study of amlitelimab for the treatment of participants with moderate-to-severe asthma. The study will have a double-blind treatment period...

Enrolling
Asthma
Drug: Placebo
Drug: Amlitelimab
Locations recently updated

This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to...

Enrolling
Asthma
Drug: Placebo
Drug: Dupilumab

Primary Objective:Primary population (former smokers cohort):* Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of ac...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Itepekimab SAR440340

Trial sponsors

Sanofi logo
Roche logo
Sumitomo Pharma logo
N
A
Amgen logo
A
Avillion logo
Merck Sharp & Dohme (MSD) logo
Perrigo logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems